Matches in Wikidata for { <http://www.wikidata.org/entity/Q102129889> ?p ?o ?g. }
Showing items 1 to 77 of
77
with 100 items per page.
- Q102129889 description "2020 ވަނަ އަހަރުގެ ނޮވެމްބަރުމަހުގެ 17ވަނަ ދުވަހު ޝާއިރުކުރެވުނު ސައިންޓިފިކް ލިޔުމެއް" @default.
- Q102129889 description "artículu científicu espublizáu en payares de 2020" @default.
- Q102129889 description "scientific article published on 17 November 2020" @default.
- Q102129889 description "wetenschappelijk artikel" @default.
- Q102129889 description "наукова стаття, опублікована 17 листопада 2020" @default.
- Q102129889 name "Long-term efficacy of dolutegravir plus lamivudine for maintenance of HIV viral suppression in adults with and without historical resistance to lamivudine: Week 96 results of ART-PRO pilot study" @default.
- Q102129889 name "Long-term efficacy of dolutegravir plus lamivudine for maintenance of HIV viral suppression in adults with and without historical resistance to lamivudine: Week 96 results of ART-PRO pilot study" @default.
- Q102129889 name "Long-term efficacy of dolutegravir plus lamivudine for maintenance of HIV viral suppression in adults with and without historical resistance to lamivudine: Week 96 results of ART-PRO pilot study" @default.
- Q102129889 type Item @default.
- Q102129889 label "Long-term efficacy of dolutegravir plus lamivudine for maintenance of HIV viral suppression in adults with and without historical resistance to lamivudine: Week 96 results of ART-PRO pilot study" @default.
- Q102129889 label "Long-term efficacy of dolutegravir plus lamivudine for maintenance of HIV viral suppression in adults with and without historical resistance to lamivudine: Week 96 results of ART-PRO pilot study" @default.
- Q102129889 label "Long-term efficacy of dolutegravir plus lamivudine for maintenance of HIV viral suppression in adults with and without historical resistance to lamivudine: Week 96 results of ART-PRO pilot study" @default.
- Q102129889 prefLabel "Long-term efficacy of dolutegravir plus lamivudine for maintenance of HIV viral suppression in adults with and without historical resistance to lamivudine: Week 96 results of ART-PRO pilot study" @default.
- Q102129889 prefLabel "Long-term efficacy of dolutegravir plus lamivudine for maintenance of HIV viral suppression in adults with and without historical resistance to lamivudine: Week 96 results of ART-PRO pilot study" @default.
- Q102129889 prefLabel "Long-term efficacy of dolutegravir plus lamivudine for maintenance of HIV viral suppression in adults with and without historical resistance to lamivudine: Week 96 results of ART-PRO pilot study" @default.
- Q102129889 P1433 Q102129889-D9A393E6-2A21-490C-A6B1-8B051E69E5AE @default.
- Q102129889 P1476 Q102129889-E2056B30-FB58-4657-85EE-B67F7125B8A7 @default.
- Q102129889 P2093 Q102129889-073BE4DD-EED0-47BC-8BDB-1FE5AB1EB346 @default.
- Q102129889 P2093 Q102129889-2BE75A3B-2984-450B-B856-2EE279C481D6 @default.
- Q102129889 P2093 Q102129889-3FBFF19F-A794-40EE-AA0F-7CE79B227D23 @default.
- Q102129889 P2093 Q102129889-49457C8C-99B5-498F-956D-BA2EE897BFDA @default.
- Q102129889 P2093 Q102129889-60ED8552-055C-4ADB-99FE-EE849C6F04E3 @default.
- Q102129889 P2093 Q102129889-61A6D798-C352-481D-9552-FCF8E053811B @default.
- Q102129889 P2093 Q102129889-6A0DEBDE-5F32-4CA7-AF44-B7FD6D510F64 @default.
- Q102129889 P2093 Q102129889-7B80DB0E-B754-43B7-BA41-BB1F8535834B @default.
- Q102129889 P2093 Q102129889-83A4605B-F618-4435-AB2D-8A90F0C601FE @default.
- Q102129889 P2093 Q102129889-914BF0AA-DA32-4DDA-AF4C-60F32A708F70 @default.
- Q102129889 P2093 Q102129889-94028D81-7831-42BC-AFC5-B905C251DFB8 @default.
- Q102129889 P2093 Q102129889-9B5FF56E-E8E6-418D-BED4-BE33078FDC5E @default.
- Q102129889 P2093 Q102129889-9FFCD504-E18C-4CA8-B341-4387E97850CF @default.
- Q102129889 P2093 Q102129889-A59AB666-1F10-4C59-A0EF-3BE35928C83D @default.
- Q102129889 P2093 Q102129889-A7F29CC5-F022-4170-B557-4D35EAA5D901 @default.
- Q102129889 P2093 Q102129889-AD89466F-B260-470E-8B07-D4F1E8D3D875 @default.
- Q102129889 P2093 Q102129889-B6808B30-8841-4A5F-B723-B93413FB0350 @default.
- Q102129889 P2093 Q102129889-C92B918E-C20C-4D0C-8C4F-813DE7000AB1 @default.
- Q102129889 P2093 Q102129889-D8415B97-DF9A-4845-94D3-7A746D110A18 @default.
- Q102129889 P2093 Q102129889-DFD04DB8-8952-4B63-99CB-105FA0E7262E @default.
- Q102129889 P2093 Q102129889-EB673941-DB24-4DD5-8683-83965E031415 @default.
- Q102129889 P2093 Q102129889-FAC36B5F-9AF2-4EBC-A1DA-5A3DA2A42E87 @default.
- Q102129889 P31 Q102129889-A94D0CFA-88A1-4B7E-BA7B-DA6EF0C9C0DD @default.
- Q102129889 P356 Q102129889-DBF6EEB8-9DE0-44F3-9F87-A942B526B48F @default.
- Q102129889 P577 Q102129889-1612DBB6-5094-4AA3-827C-CD5CD06ABFD5 @default.
- Q102129889 P698 Q102129889-D9CF256B-76D4-47C8-B655-3652618C7A6B @default.
- Q102129889 P921 Q102129889-15B3F4F1-3918-4018-861F-0393C5A4EF4C @default.
- Q102129889 P921 Q102129889-4175438B-AE5B-4B3C-A480-E93DB7E35645 @default.
- Q102129889 P356 DKAA479 @default.
- Q102129889 P698 33200210 @default.
- Q102129889 P1433 Q6294770 @default.
- Q102129889 P1476 "Long-term efficacy of dolutegravir plus lamivudine for maintenance of HIV viral suppression in adults with and without historical resistance to lamivudine: Week 96 results of ART-PRO pilot study" @default.
- Q102129889 P2093 "ART-PRO PI16/00837-PI16/00678 study group" @default.
- Q102129889 P2093 "Andrés Esteban-Cantos" @default.
- Q102129889 P2093 "Asunción Hernando" @default.
- Q102129889 P2093 "Belén Alejos" @default.
- Q102129889 P2093 "David Rial-Crestelo" @default.
- Q102129889 P2093 "Federico Pulido" @default.
- Q102129889 P2093 "José Ramón Arribas" @default.
- Q102129889 P2093 "Juan Miguel Castro" @default.
- Q102129889 P2093 "Julen Cadiñanos" @default.
- Q102129889 P2093 "Laura Bermejo-Plaza" @default.
- Q102129889 P2093 "Lourdes Dominguez-Dominguez" @default.
- Q102129889 P2093 "Luz Martin-Carbonero" @default.
- Q102129889 P2093 "Mario Mayoral" @default.
- Q102129889 P2093 "Mireia Santacreu-Guerrero" @default.
- Q102129889 P2093 "Mónica Garcia-Alvarez" @default.
- Q102129889 P2093 "Otilia Bisbal" @default.
- Q102129889 P2093 "Paula Aranguren-Rivas" @default.
- Q102129889 P2093 "Rafael Delgado" @default.
- Q102129889 P2093 "Rafael Rubio" @default.
- Q102129889 P2093 "Rocío Montejano" @default.
- Q102129889 P2093 "Rosa de Miguel" @default.
- Q102129889 P2093 "Victoria Moreno" @default.
- Q102129889 P31 Q13442814 @default.
- Q102129889 P356 "10.1093/JAC/DKAA479" @default.
- Q102129889 P577 "2020-11-17T00:00:00Z" @default.
- Q102129889 P698 "33200210" @default.
- Q102129889 P921 Q422631 @default.
- Q102129889 P921 Q937224 @default.